Brief: Sol-Gel Technologies Announces Positive Update Related To FDA Review Status Of Epsolay
Dec 21 (Reuters) - Sol Gel Technologies Ltd SLGL.O :
* SOL-GEL TECHNOLOGIES ANNOUNCES POSITIVE UPDATE RELATED TO
FDA
REVIEW STATUS OF EPSOLAY®
* SOL GEL TECHNOLOGIES - FDA INFORMS CO, IT INTENDS TO
CONDUCT
PRE-APPROVAL INSPECTION OF PRODUCTION SITE FOR EPSOLAY DURING
WEEK OF FEB 14TH, 2022
Source text for Eikon: ID:nGNX88GYKT
Further company coverage: SLGL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on SOL-GEL TECHNOLOGIES
See all newsIsraeli dermatology firm Sol-Gel's Q2 revenue drops sharply on prior-year IP sale
SOL-GEL TECHNOLOGIES LTD. expected to post a loss of $2.57 a share - Earnings Preview
Sol-Gel Q1 revenue falls sharply on milestone payment impact
Brief: Sol-Gel Technologies Ltd. Q1 Revenue USD 100 Thousand
Brief: Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering